Literature DB >> 11751653

Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease.

S Møller1, J H Henriksen.   

Abstract

The systemic circulation in patients with cirrhosis is hyperdynamic with an increased cardiac output and heart rate and a reduced systemic vascular resistance as the most pronounced alterations. The concomitant cardiac dysfunction has recently been termed "cirrhotic cardiomyopathy", which is an entity different from that seen in alcoholic heart muscle disease. Clinically, these patients present with sodium fluid retention and strain often unmasks the presence of latent heart failure. No specific treatment can yet be recommended but caution should be used with respect to procedures that may stress the heart such as shunt implantation and liver transplantation.

Entities:  

Mesh:

Year:  2002        PMID: 11751653      PMCID: PMC1766971          DOI: 10.1136/heart.87.1.9

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  110 in total

Review 1.  Endogenous factors involved in the control of arterial tone in cirrhosis.

Authors:  R Moreau; D Lebrec
Journal:  J Hepatol       Date:  1995-03       Impact factor: 25.083

2.  Impaired responsiveness to angiotensin II in experimental cirrhosis.

Authors:  A Bomzon
Journal:  Hepatology       Date:  1994-07       Impact factor: 17.425

3.  Assessment of central blood volume in cirrhosis by radionuclide angiography: what does it really mean?

Authors:  J H Henriksen; S Møller; F Bendtsen; H Ring-Larsen; K H Stokholm; J Møgelvang; T I Sørensen; A L Gerbes
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

4.  Hyperdynamic circulation of advanced cirrhosis: a re-appraisal based on posture-induced changes in hemodynamics.

Authors:  M Bernardi; L Fornalè; C Di Marco; F Trevisani; M Baraldini; A Gasbarrini; C De Collibus; F Zacà; A Ligabue; A Colantoni
Journal:  J Hepatol       Date:  1995-03       Impact factor: 25.083

5.  Noninvasive 24-hour ambulatory arterial blood pressure monitoring in cirrhosis.

Authors:  S Møller; N Wiinberg; J H Hernriksen
Journal:  Hepatology       Date:  1995-07       Impact factor: 17.425

6.  Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis.

Authors:  R D Grose; J Nolan; J F Dillon; M Errington; W J Hannan; I A Bouchier; P C Hayes
Journal:  J Hepatol       Date:  1995-03       Impact factor: 25.083

7.  Circulating antibodies to cardiac protein-acetaldehyde adducts in alcoholic heart muscle disease.

Authors:  A A Harcombe; L Ramsay; J G Kenna; J Koskinas; H J Why; P J Richardson; P L Weissberg; G J Alexander
Journal:  Clin Sci (Lond)       Date:  1995-03       Impact factor: 6.124

8.  Cardiovascular effects of octreotide in patients with hepatic cirrhosis.

Authors:  P A McCormick; J Chin; L Greenslade; S Karatapanis; R Dick; N McIntyre; A K Burroughs
Journal:  Hepatology       Date:  1995-05       Impact factor: 17.425

9.  Vasodilatory state of decompensated cirrhosis: relation to hepatic dysfunction, ascites, and vasoactive substances.

Authors:  H S Friedman; N Cirillo; F Schiano; P Nathan; S Khan; H Rosero; M Vaseghi; T Sacchi; B Vasavada; L Bjornson
Journal:  Alcohol Clin Exp Res       Date:  1995-02       Impact factor: 3.455

Review 10.  Systemic hypotension and renal failure in obstructive jaundice-mechanistic and therapeutic aspects.

Authors:  J Green; O S Better
Journal:  J Am Soc Nephrol       Date:  1995-05       Impact factor: 10.121

View more
  85 in total

Review 1.  Cardiohepatic syndrome.

Authors:  Gerhard Poelzl; Johann Auer
Journal:  Curr Heart Fail Rep       Date:  2015-02

2.  Cirrhotic cardiomyopathy: an endocannabinoid connection?

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

Review 3.  The extrahepatic consequences of cirrhosis.

Authors:  Jin Kee Ho; Eric Yoshida
Journal:  MedGenMed       Date:  2006-03-02

Review 4.  Cardiovascular determinants of survival in cirrhosis.

Authors:  Samuel S Lee; Hongqun Liu
Journal:  Gut       Date:  2007-06       Impact factor: 23.059

Review 5.  Liver cirrhosis and arterial hypertension.

Authors:  Jens H Henriksen; Soren Moller
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

6.  Origins of cardiac dysfunction in cirrhosis.

Authors:  W Jiménez; V Arroyo
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

7.  Can non-invasive measurements aid clinical assessment of volume in patients with cirrhosis?

Authors:  Andrew Davenport; Banwari Argawal; Gavin Wright; Konstantinos Mantzoukis; Rumyana Dimitrova; Joseph Davar; Panayota Vasianopoulou; Andrew K Burroughs
Journal:  World J Hepatol       Date:  2013-08-27

Review 8.  Hepato-cardiac disorders.

Authors:  Yasser Mahrous Fouad; Reem Yehia
Journal:  World J Hepatol       Date:  2014-01-27

9.  QT interval prolongation in end-stage liver disease cannot be explained by nonhepatic factors.

Authors:  Divyang Patel; Prabhpreet Singh; William Katz; Christopher Hughes; Kapil Chopra; Jan Němec
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-04-24       Impact factor: 1.468

10.  Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

Authors:  J H Henriksen; J P Gøtze; S Fuglsang; E Christensen; F Bendtsen; S Møller
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.